Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2012 | 08-2012 | 05-2012 | 02-2012 | 11-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47 | -280 | -224 | -180 | -140 |
| Depreciation Amortization | 0 | 10 | 10 | 10 | 6 |
| Other Working Capital | 17 | 30 | 27 | 10 | 9 |
| Other Operating Activity | 0 | 130 | 95 | 100 | 95 |
| Operating Cash Flow | $-30 | $-110 | $-91 | $-60 | $-30 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2 | -2 | -1 | 0 |
| Investing Cash Flow | $N/A | $-2 | $-2 | $-1 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20 | 65 | 40 | N/A | N/A |
| Debt Repayment | -6 | -28 | -26 | N/A | N/A |
| Common Stock Issued | 20 | 75 | 75 | N/A | N/A |
| Other Financing Activity | 0 | -2 | 0 | 60 | 30 |
| Financing Cash Flow | $34 | $110 | $89 | $60 | $30 |
| Beginning Cash Position | 2 | 10 | 11 | 10 | 10 |
| End Cash Position | 6 | 2 | 7 | 7 | 10 |
| Net Cash Flow | $4 | $-9 | $-4 | $-4 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30 | -110 | -91 | -60 | -30 |
| Capital Expenditure | N/A | -2 | -2 | N/A | N/A |
| Free Cash Flow | -30 | -112 | -93 | -60 | -30 |